News

FDA authorizes Moderna and Pfizer-BioNTech omicron-specific boosters

By Abigail Adcox
Published August 31, 2022 1:58pm ET
Add Washington Examiner on Google
FDA authorizes Moderna and Pfizer-BioNTech omicron-specific boosters
The Food and Drug Administration has authorized Moderna’s and Pfizer-BioNTech’s updated COVID-19 booster vaccines that target the highly contagious omicron variant as the federal government prepares to roll out the boosters in the coming weeks. Moderna’s has been authorized as a booster for individuals 18 and older, while Pfizer-BioNTech’s is for use in people 12 […]

The Food and Drug Administration has authorized Moderna’s and Pfizer-BioNTech’s updated COVID-19 booster vaccines that target the highly contagious omicron variant as the federal government prepares to roll out the boosters in the coming weeks.

Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.

Tag:

COVID-19 FDA Featured Video Featured Video Homepage Pfizer Vaccines